GLAUKOS Corp (GKOS) stock
GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30215% above fair value
$243.25−1.63 (-0.67%)
Close on Nov 17, 2026Market cap $14.40BP/E –Yield –
Glaukos total assets
Total assets on the balance sheet at the end of each period.
Glaukos's total assets was $979.53M at Sep 30, 2026. For fiscal 2025 it was $893.49M, down 8.3% from the year before. Over ten years it grew 22.6% a year on average. The highest annual figure on record is $1.05B in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $893.49M | -8.3% |
| FY2024 | Dec 31, 2024 | $974.76M | +3.7% |
| FY2023 | Dec 31, 2023 | $940.41M | -6.2% |
| FY2022 | Dec 31, 2022 | $1.00B | -4.5% |
| FY2021 | Dec 31, 2021 | $1.05B | +4.4% |
| FY2020 | Dec 31, 2020 | $1.01B | +22.9% |
| FY2019 | Dec 31, 2019 | $818.40M | +295.4% |
| FY2018 | Dec 31, 2018 | $206.97M | +24.8% |
| FY2017 | Dec 31, 2017 | $165.84M | +23.4% |
| FY2016 | Dec 31, 2016 | $134.37M | +15.2% |
| FY2015 | Dec 31, 2015 | $116.66M | +348.3% |
| FY2014 | Dec 31, 2014 | $26.02M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $979.53M | -2.0% |
| Q2 FY2026 | Jun 30, 2026 | $920.52M | -6.7% |
| Q1 FY2026 | Mar 31, 2026 | $893.33M | -7.5% |
| Q4 FY2025 | Dec 31, 2025 | $893.49M | -8.3% |
| Q3 FY2025 | Sep 30, 2025 | $999.38M | +7.9% |
| Q2 FY2025 | Jun 30, 2025 | $986.96M | +7.3% |
| Q1 FY2025 | Mar 31, 2025 | $966.18M | +3.5% |
| Q4 FY2024 | Dec 31, 2024 | $974.76M | +3.7% |
| Q3 FY2024 | Sep 30, 2024 | $926.54M | -2.3% |
| Q2 FY2024 | Jun 30, 2024 | $919.68M | -3.9% |
| Q1 FY2024 | Mar 31, 2024 | $933.34M | -4.0% |
| Q4 FY2023 | Dec 31, 2023 | $940.41M | -6.2% |
| Q3 FY2023 | Sep 30, 2023 | $948.63M | -5.9% |
| Q2 FY2023 | Jun 30, 2023 | $956.74M | -7.2% |
| Q1 FY2023 | Mar 31, 2023 | $972.59M | -7.6% |
| Q4 FY2022 | Dec 31, 2022 | $1.00B | -4.5% |
| Q3 FY2022 | Sep 30, 2022 | $1.01B | -5.2% |
| Q2 FY2022 | Jun 30, 2022 | $1.03B | -1.2% |
| Q1 FY2022 | Mar 31, 2022 | $1.05B | +2.9% |
| Q4 FY2021 | Dec 31, 2021 | $1.05B | +4.4% |
| Q3 FY2021 | Sep 30, 2021 | $1.06B | +7.0% |
| Q2 FY2021 | Jun 30, 2021 | $1.04B | +4.8% |
| Q1 FY2021 | Mar 31, 2021 | $1.02B | +31.2% |
| Q4 FY2020 | Dec 31, 2020 | $1.01B | +22.9% |
| Q3 FY2020 | Sep 30, 2020 | $994.51M | +223.5% |
| Q2 FY2020 | Jun 30, 2020 | $995.73M | +229.6% |
| Q1 FY2020 | Mar 31, 2020 | $779.72M | +241.9% |
| Q4 FY2019 | Dec 31, 2019 | $818.40M | +295.4% |
| Q3 FY2019 | Sep 30, 2019 | $307.44M | +61.4% |
| Q2 FY2019 | Jun 30, 2019 | $302.09M | +76.6% |
| Q1 FY2019 | Mar 31, 2019 | $228.04M | +39.6% |
| Q4 FY2018 | Dec 31, 2018 | $206.97M | +24.8% |
| Q3 FY2018 | Sep 30, 2018 | $190.50M | +24.8% |
| Q2 FY2018 | Jun 30, 2018 | $171.09M | +17.6% |
| Q1 FY2018 | Mar 31, 2018 | $163.35M | +18.5% |
| Q4 FY2017 | Dec 31, 2017 | $165.84M | +23.4% |
| Q3 FY2017 | Sep 30, 2017 | $152.61M | – |
| Q2 FY2017 | Jun 30, 2017 | $145.53M | – |
| Q1 FY2017 | Mar 31, 2017 | $137.90M | – |
| Q4 FY2016 | Dec 31, 2016 | $134.37M | – |
See a number that looks wrong?